Skip to main content
Caplight Logo









Moonwalk Biosciences

Moonwalk Biosciences

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://moonwalk.bio/

Last Round

Series A

Jan 4, 2024

Est. Valuation

$150M

Total Funding Raised

$57M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Moonwalk Biosciences is a biotechnology company that develops precision epigenetic therapies by coupling an epigenetic discovery platform with precise engineering to reprogram cells to a healthy state.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

epigenetic medicineepigenome editingepigenetic engineeringgene regulationdrug discoveryprecision medicinebiotech platformbioinformaticsepigenetic therapyepigenetic profilingepigenetic drugsepigenetic editingtherapeutic developmentAI-native biotechepigenetic startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Moonwalk Biosciences Comparables

Compare Moonwalk Biosciences with similar companies based on industry and business-model similarity.

Moonwalk Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Tune Therapeutics
89%
Chroma Medicine
88%
Epigenic Therapeutics
88%

Moonwalk Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 4, 2024

Key People

Founding team and executive leadership

Alex Aravanis

Chief Executive Officer And Co-Founder

Founding Team

Moonwalk Biosciences Investors

Notable investors and investment history

Moonwalk Biosciences investors
InvestorRounds
Future VenturesSeries A
GVSeries A
Khosla VenturesSeries A
ARCH Venture PartnersSeries A
ARCH Venture PartnersSeries A
Alpha Wave GlobalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 38% MoM, reaching 4.6K.

  • Jan 4, 2024

    $57M round led by ARCH Venture Partners and Future Ventures.

Moonwalk Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Moonwalk Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Moonwalk Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range20
Year Founded2022
Last FundingJan 4, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?